Works by Zuoxing Niu

Results: 7

A phase IV study to evaluate the safety of fruquintinib in Chinese patients in real-world clinical practice.

Published in:

Oncologist, 2024, v. 29, n. 8, p. e1012, doi. 10.1093/oncolo/oyae073

By:

Li, Jin;
Wang, Zhiqiang;
Zhong, Haijun;
He, Yifu;
Zhang, Chen;
Niu, Zuoxing;
Yang, Shujun;
Zhang, Tao;
Zhu, Liangjun;
Shu, Yongqian;
Gao, Yong;
Peng, Jianjun;
Song, Yan;
Li, Jian;
Yuan, Ying;
Zhang, Haibo;
Yu, Gengsheng;
Hua, Yunqi;
Xiao, Jianjun;
Fu, Jianfei

Publication type:

Article

Efficacy and safety of KN026, a bispecific anti-HER2 antibody, in combination with KN046, an anti-CTLA4/PD-L1 antibody, in patients with advanced HER2-positive nonbreast cancer: a combined analysis of a phase Ib and a phase II study.

Published in:

Signal Transduction & Targeted Therapy, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41392-025-02195-x

By:

Liu, Dan;
Gong, Jifang;
Li, Jian;
Qi, Changsong;
Niu, Zuoxing;
Liu, Bo;
Peng, Zhi;
Luo, Suxia;
Wang, Xicheng;
Wang, Yakun;
Zhao, Rusen;
Chen, Lilin;
Deng, Ting;
Li, Zhen;
Chen, Lei;
Fang, Meimei;
Yang, Hongwei;
Lu, Linzhi;
Zhang, Yanming;
Kang, Fengling

Publication type:

Article

Current management of chemotherapy-induced neutropenia in adults: key points and new challenges.

Published in:

Cancer Biology & Medicine, 2020, v. 17, n. 4, p. 896, doi. 10.20892/j.issn.2095-3941.2020.0069

By:

Yi Ba;
Yuankai Shi;
Wenqi Jiang;
Jifeng Feng;
Ying Cheng;
Li Xiao;
Qingyuan Zhang;
Wensheng Qiu;
Binghe Xu;
Ruihua Xu;
Bo Shen;
Zhiguo Luo;
Xiaodong Xie;
Jianhua Chang;
Mengzhao Wang;
Yufu Li;
Yuerong Shuang;
Zuoxing Niu;
Bo Liu;
Jun Zhang

Publication type:

Article

Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial.

Published in:

JAMA: Journal of the American Medical Association, 2021, v. 326, n. 10, p. 916, doi. 10.1001/jama.2021.12836

By:

Luo, Huiyan;
Lu, Jin;
Bai, Yuxian;
Mao, Teng;
Wang, Jun;
Fan, Qingxia;
Zhang, Yiping;
Zhao, Kuaile;
Chen, Zhendong;
Gao, Shegan;
Li, Jiancheng;
Fu, Zhichao;
Gu, Kangsheng;
Liu, Zhihua;
Wu, Lin;
Zhang, Xiaodong;
Feng, Jifeng;
Niu, Zuoxing;
Ba, Yi;
Zhang, Helong

Publication type:

Article

A Survey of Clinical Practices for Hepatocellular Carcinoma Among Experts at Tertiary Hospitals in China From 2020 to 2021.

Published in:

Cancer Innovation, 2025, v. 4, n. 3, p. 1, doi. 10.1002/cai2.70006

By:

Zhao, Hong;
Mao, Yilei;
Wang, Hongguang;
Zhou, Aiping;
Yang, Zhengqiang;
Han, Yue;
Li, Gong;
Bi, Xinyu;
Hao, Chunyi;
Wang, Xiaodong;
Zhou, Jun;
Dai, Chaoliu;
Wen, Feng;
Zhang, Jingdong;
Liu, Ruibao;
Li, Tao;
Zhao, Lei;
Niu, Zuoxing;
Wen, Tianfu;
Li, Qiu

Publication type:

Article

Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional study.

Published in:

2016

By:

Jianqiu Wu;
Yongping Song;
Liping Su;
Li Xu;
Tingchao Chen;
Zhiyun Zhao;
Mingzhi Zhang;
Wei Li;
Yu Hu;
Xiaohong Zhang;
Yuhuan Gao;
Zuoxing Niu;
Ru Feng;
Wei Wang;
Jiewen Peng;
Xiaolin Li;
Xuenong Ouyang;
Changping Wu;
Weijing Zhang;
Yun Zeng

Publication type:

journal article

Iparomlimab (QL1604) in patients with microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) unresectable or metastatic solid tumors: a pivotal, single-arm, multicenter, phase II trial.

Published in:

Journal of Hematology & Oncology, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13045-024-01627-5

By:

Bi, Feng;
Dong, Jian;
Jin, Chuan;
Niu, Zuoxing;
Yang, Wenhui;
He, Yifu;
Yu, Dajun;
Sun, Meili;
Wang, Teng;
Yin, Xianli;
Zhang, Ruixing;
Chen, Kehe;
Wang, Keming;
Wang, Zhiwu;
Li, Wei;
Zhang, Zhongtao;
Zhang, Hangyu;
Guo, Qunyi;
Wang, Xin;
Han, Lei

Publication type:

Article